Investor Ideas Podcast Corner: Dr. Sarath Malepati, Creator of the EZC Pak Talks about the Growing Antibiotic Resistance Crisis
Point Roberts, WA and Delta, BC - April 26, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source covering biotech and LOHAS, releases a new Podcast interview with Dr. Sarath Malepati, a leading expert and creator of the new over the counter supplement EZC Pak https://www.ezcpak.com/ which is the first physician formulated immune support pack designed to reduce inappropriate antibiotic use.
Dr. Sarath Malepati talks about why he created EZC Pak, the three main components of and how each one works individually and then collectively. He also shares data on the effectiveness of EZC Pak and why it is a viable solution to address the rapid growth of antibiotic resistance.
He points out, "A lot of the growth of the growth of these drug resistant infections or superbugs are a result of antibiotic resistance created by inappropriate and injudicious antibiotic use."
He also tells us that," In the US we currently now have over 2 Million drug resistance infections and over 30,000 deaths a year as a result of antibiotic resistance."
"The concept for EZC Pak is to support the immune system to recognize and deal with infections and clear them on their own, rather than create new medications that functionally attack the virus or bacteria."
EZC Pak works from a three-pronged approach:
- Echinacea supports the immune system's ability to clear infections by promoting T-cell activity, the cell type critical to cell-mediated immunity.
- Zinc is involved in virtually every aspect of our immune system's function. Iblucding processes such as metabolism, gene expression, and enzyme function.
- Vitamin C is critical to a wide range of metabolic reactions in the body, including the formation of collagen in bones, cartilage, muscle, and blood vessels, as well as the absorption of iron.
In closing he talks about the pending urgency of antibiotic resistance, "The UK Government analysis of these problems is now saying that by 2050 superbugs or drug resistant infections will kill more people than cancer."
Listen to podcast: http://www.investorideas.com/Audio/Podcasts/042617-DrSarathMalepati.mp3
To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.
About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
Sectors we cover in include tech, bitcoin and blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.
The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.